Abstract:Motivation: Currently there are no curative anticancer drugs, and drug resistance is often acquired after drug treatment. One of the reasons is that cancers are complex diseases, regulated by multiple signaling pathways and cross talks among the pathways. It is expected that drug combinations can reduce drug resistance and improve patients’ outcomes. In clinical practice, the ideal and feasible drug combinations are combinations of existing Food and Drug Administration-approved drugs or bioactive compounds that are already used on patients or have entered clinical trials and passed safety tests. These drug combinations could directly be used on patients with less concern of toxic effects. However, there is so far no effective computational approach to search effective drug combinations from the enormous number of possibilities. Results: In this study, we propose a novel systematic computational tool DrugComboRanker to prioritize synergistic drug combinations and uncover their mechanisms of action. We first build a drug functional network based on their genomic profiles, and partition the network into numerous drug network communities by using a Bayesian non-negative matrix factorization approach. As drugs within overlapping community share common mechanisms of action, we next uncover potential targets of drugs by applying a recommendation system on drug communities. We meanwhile build disease-specific signaling networks based on patients’ genomic profiles and interactome data. We then identify drug combinations by searching drugs whose targets are enriched in the complementary signaling modules of the disease signaling network. The novel method was evaluated on lung adenocarcinoma and endocrine receptor positive breast cancer, and compared with other drug combination approaches. These case studies discovered a set of effective drug combinations top ranked in our prediction list, and mapped the drug targets on the disease signaling network to highlight the mechanisms of action of the drug combinations. Availability and implementation: The program is available on request. Contact: stwong@tmhs.org

Neighbor Communities in Drug Combination Networks Characterize Synergistic Effect.

Dcdb: Drug Combination Database

Exploring Drug Combinations in Genetic Interaction Network

Predicting drug synergy using a network propagation inspired machine learning framework

DrugComboRanker: Drug Combination Discovery Based on Target Network Analysis

Prediction of Synergistic Anti-Cancer Drug Combinations Based on Drug Target Network and Drug Induced Gene Expression Profiles

KGANSynergy: knowledge graph attention network for drug synergy prediction

Mechanisms of Drug Combinations: Interaction and Network Perspectives.

Prediction of Drug Synergy and Antagonism Based on Drug-Drug Interaction Network

A network-based trans-omics approach for predicting synergistic drug combinations

Synergistic and Antagonistic Drug Combinations Depend on Network Topology.

DTSyn: a Dual-Transformer-based Neural Network to Predict Synergistic Drug Combinations

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

A Network Embedding Framework Based on Integrating Multiplex Network for Drug Combination Prediction

A Knowledge Graph Embedding-Based Method for Predicting the Synergistic Effects of Drug Combinations

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations

Deep graph embedding for prioritizing synergistic anticancer drug combinations

DRUGSYNC: Prediction of Synergistic Drug Combinations Using GCN Graph Convolutional Network based and Pre-learned Drug-induced Gene Expression Profiles

SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction

Advances in computational approaches in identifying synergistic drug combinations.

GraphSynergy: a network-inspired deep learning model for anticancer drug combination prediction